IFP Advisors’s TherapeuticsMD TXMD Stock Holding History

IFP Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46	Hold	21	–	–	﹤0.01%	5030
2026 Q1	$42	Hold	21	–	–	﹤0.01%	4852
2025 Q4	$34	Hold	21	–	–	﹤0.01%	4751
2025 Q3	$23	Hold	21	–	–	﹤0.01%	4747
2025 Q2	$24	Hold	21	–	–	﹤0.01%	4840
2025 Q1	$19	Sell	21 -59	-74%	-$59	﹤0.01%	4171
2024 Q4	$69	Hold	80	–	–	﹤0.01%	4159
2024 Q3	$133	Hold	80	–	–	﹤0.01%	3224
2024 Q2	$129	Buy	80 +20	+33%	+$40	﹤0.01%	3160
2024 Q1	$137	Buy	+60	New	+$139	﹤0.01%	3048
2023 Q3	–	Sell	-16	Closed	-$66	–	3554
2023 Q2	$66	Hold	16	–	–	﹤0.01%	3372
2023 Q1	$77	Buy	+16	New	+$77	﹤0.01%	3316
2019 Q1	–	Sell	-20	Closed	-$4K	–	3385
2018 Q4	$4K	Sell	20 -2	-9%	-$488	﹤0.01%	2965
2018 Q3	$7K	Hold	22	–	–	﹤0.01%	3072
2018 Q2	$7K	Sell	22 -10	-31%	-$3.06K	﹤0.01%	3113
2018 Q1	$10K	Hold	32	–	–	﹤0.01%	2801
2017 Q4	$10K	Sell	32 -74	-70%	-$20.6K	﹤0.01%	2842
2017 Q3	$28K	Sell	106 -22	-17%	-$6.36K	﹤0.01%	2390
2017 Q2	$34K	Sell	128 -2	-2%	-$501	﹤0.01%	2237
2017 Q1	$47K	Sell	130 -4	-3%	-$1.24K	﹤0.01%	1972
2016 Q4	$39K	Buy	134 +120	+857%	+$37.2K	﹤0.01%	2030
2016 Q3	$5K	Sell	14 -2	-13%	-$730	﹤0.01%	3258
2016 Q2	$7K	Buy	+16	New	+$6.59K	﹤0.01%	2963

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

IFP Advisors's TXMD Position: Q2 2026 in Review

IFP Advisors held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 21 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #5030.

IFP Advisors first reported a position in TXMD in Q2 2016 and has held it in 23 quarters since. The position peaked at $47K in Q1 2017. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

IFP Advisors held 21 shares of TherapeuticsMD worth $46 as of Q2 2026.
IFP Advisors left its TherapeuticsMD share count unchanged in Q2 2026.
TherapeuticsMD made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5030 holding.
IFP Advisors first reported a position in TherapeuticsMD in Q2 2016 and has held it in 23 quarters since.
IFP Advisors's TherapeuticsMD position peaked at $47K in Q1 2017.
44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.